Tigatuzumab
Based on 1 Customer Validation
Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). Tigatuzumab induces cell apoptosis of cancer cells and inhibits tumor growth in vivo. Tigatuzumab can be used for the research of cancer.
For research use only. We do not sell to patients.
- Purity: 98.18%
- CAS No.: 918127-53-4
- Molecular Weight:144.64 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Human IgG1 kappa
Human
TNFRSF10B/TRAILR2/CD262
Tigatuzumab is sensitive to MIA PaCa-2 cells and BxPC-3 cells with IC50 values of 2.95 and 8.21 μg/mL, respectively[1]. Tigatuzumab (3-8 μg/mL; 5 h) induces apoptosis of cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MIA PaCa-2 and BxPC-3 cell lines
-
Concentration:3 and 8 μg/mL
-
Incubation Time:5 hours
-
Result:Induced cell apoptosis, and the methionine restriction increased the caspase activation and apoptosis in pancreatic cancer cells.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Nude mice with MIA PaCa-2-RFP human pancreatic cancer cells injection[1]
-
Dosage:3 mg/kg
-
Administration:Intravenous injection; 3 mg/kg weekly for 4 weeks
-
Result:Reduced the tumor volume and decreased the density of viable cancer cells in tumors.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Human IgG1 kappa
ELISA, FACS, Functional assay
-
Immobilized TRAIL R2/TNFRSF10B Protein, Human (HY-P72779) can bind Tigatuzumab. The EC50 for this effect is 4.074 ng/mL. -
Flow cytometric analysis of 1.5X106 HEPG2 cells with Tigatuzumab (HY-P99270, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa, Isotype Control (HY-P99001, blue) was used as the isotype control.
Chemical Information
-
CAS No. 918127-53-4
-
Appearance Liquid
-
Molecular Weight 144.64 kDa
-
Color Colorless to light yellow
-
SMILES
[Tigatuzumab]
-
Synonyms
CS-1008; Anti-Human TRAIL-R2 Recombinant Antibody
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (259 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Portuguese - PT (252 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)